Silo Pharma, Inc.

SILO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $294.6K $2.0M $279 $1.8K $47.5K
Accounts Receivable — — — — —
Inventory — — — — —
Total Current Assets $1.6M — $279 $1.8K $47.5K
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $1.6M $2.2M $279 $1.8K $47.5K
Liabilities
Accounts Payable $38.3K $2.1K $20.7K $3.5K $0
Total Current Liabilities $38.3K — $25.7K $3.5K $0
Long-Term Debt — — — — —
Total Liabilities $438.3K $18.7K $41.5K $3.5K $0
Stockholders' Equity
Retained Earnings — — — — —
Total Stockholders' Equity $1.2M $1.8M $-41.2K $-1.7K $47.5K
← Newer Page 2 of 2 Older →